Resonate Blends, Inc. (KOAN)

Market Cap	466.56K +10.7%
Revenue (ttm)	2.23M +2,100.9%
Net Income	1.14M
EPS	0.01
Shares Out	291.60M
PE Ratio	0.16
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,825,097
Open	0.0015
Previous Close	0.0016
Day's Range	0.0015 - 0.0015
52-Week Range	0.0006 - 0.0235
Beta	3.83
RSI	36.07
Earnings Date	Apr 17, 2026

About Resonate Blends

Resonate Blends, Inc. engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine. It focuses on marketing licensed patent-pending natural stem cell mobilizing agents for enhancing individual's ability to mobilize their own adult stem cells from their bone marrow. The company also has a license to market a dual acting all-natural diet aid to help control hunger through normal body signals to the brain and stomach. In addition, it is involved in the research and development activities focusi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: James Zimbler
• Employees: 6
• Stock Exchange: OTCMKTS
• Ticker Symbol: KOAN

Financial Performance

In 2024, Resonate Blends's revenue was $1.90 million, an increase of 11414.54% compared to the previous year's $16,468. Losses were -$2.13 million, 50.7% more than in 2023.